Ramin Farzaneh-Far, Chief Medical Officer at Ra Pharmaceuticals, Inc. (RARX), sold 21,190 shares at $21.41 ($463K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $463k RARX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.41 | 3,411 | $73K | 15.8% |
| 2 | $21.41 | 3,411 | $73K | 15.8% |
| 3 | $22.04 | 7,184 | $158K | 34.2% |
| 4 | $22.04 | 7,184 | $158K | 34.2% |
| Total | $21.84 avg | 21,190 | $463K | 100% |
| Filing → |
| RARX | SELL | 2020-01-16 | $995K | — | Filing → |
| RARX | SELL | 2019-12-18 | $1.0M | — | Filing → |
| RARX | SELL | 2019-11-18 | $989K | — | Filing → |